A Validated Proteomic Signature of Basal-like Triple-Negative Breast Cancer Subtypes Obtained from Publicly Available Data
These findings suggest the existence of novel molecular signatures that could improve TNBC classification, prognosis, and potential therapeutic targeting.
Authors
- Edoardo Saccenti (ORCID: https://orcid.org/0000-0001-8284-4829)
- María Suárez‐Diez (ORCID: https://orcid.org/0000-0001-5845-146X)
- Cristina Furlan (ORCID: https://orcid.org/0000-0003-1416-3647)
Institutions
- Wageningen University & Research (NL)
Publication Details
- Journal
- Cancers
- Published
- 2025-08-08
- DOI
- https://doi.org/10.3390/cancers17162601
- Citations
- 1
- Primary Topic
- Molecular Biology Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.81